FDA action on cannabis firm’s drug for COVID-19 patients sends Philly pharma firm’s stock soaring

6/3/20–Shares in Philadelphia-based cannabis company FSD Pharma spiked 324% in premarket trading this morning on news that it had been granted approval by the Food and Drug Administration to submit an application for a clinical trial using a synthetic drug that mimics the action of a molecule found in marijuana to treat COVID-19. Read